Correlation Between Eli Lilly and MiMedx
Can any of the company-specific risk be diversified away by investing in both Eli Lilly and MiMedx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and MiMedx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eli Lilly and and MiMedx Group, you can compare the effects of market volatilities on Eli Lilly and MiMedx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of MiMedx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and MiMedx.
Diversification Opportunities for Eli Lilly and MiMedx
Pay attention - limited upside
The 3 months correlation between Eli and MiMedx is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and MiMedx Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MiMedx Group and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with MiMedx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MiMedx Group has no effect on the direction of Eli Lilly i.e., Eli Lilly and MiMedx go up and down completely randomly.
Pair Corralation between Eli Lilly and MiMedx
Considering the 90-day investment horizon Eli Lilly and is expected to under-perform the MiMedx. But the stock apears to be less risky and, when comparing its historical volatility, Eli Lilly and is 2.26 times less risky than MiMedx. The stock trades about -0.12 of its potential returns per unit of risk. The MiMedx Group is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest 618.00 in MiMedx Group on September 18, 2024 and sell it today you would earn a total of 298.00 from holding MiMedx Group or generate 48.22% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Eli Lilly and vs. MiMedx Group
Performance |
Timeline |
Eli Lilly |
MiMedx Group |
Eli Lilly and MiMedx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Eli Lilly and MiMedx
The main advantage of trading using opposite Eli Lilly and MiMedx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, MiMedx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MiMedx will offset losses from the drop in MiMedx's long position.Eli Lilly vs. Emergent Biosolutions | Eli Lilly vs. Neurocrine Biosciences | Eli Lilly vs. Teva Pharma Industries | Eli Lilly vs. Haleon plc |
MiMedx vs. Monte Rosa Therapeutics | MiMedx vs. Design Therapeutics | MiMedx vs. Werewolf Therapeutics | MiMedx vs. Ikena Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Equity Valuation Check real value of public entities based on technical and fundamental data |